The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study
Open accessAbstract
A potent, synthetic cannabinoid was radiolabeled and used to characterize and precisely localize cannabinoid receptors in slide-mounted sections of rat brain and pituitary. Assay conditions for 3H-CP55,940 binding in Tris-HCl buffer with 5% BSA were optimized, association and dissociation rate constants determined, and the equilibrium dissociation constant (Kd) calculated (21 nM by liquid scintillation counting, 5.2 nM by quantitative autoradiography). The results of competition studies, using several synthetic cannabinoids, add to prior data showing enantioselectivity of binding and correlation of in vitro potencies with potencies in biological assays of cannabinoid actions. Inhibition of binding by guanine nucleotides was selective and profound: Nonhydrolyzable analogs of GTP and GDP inhibited binding by greater than 90%, and GMP and the nonhydrolyzable ATP analog showed no inhibition. Autoradiography showed great heterogeneity of binding in patterns of labeling that closely conform to cytoarchitectural and functional domains. Very dense 3H-CP55,940 binding is localized to the basal ganglia (lateral caudate-putamen, globus pallidus, entopeduncular nucleus, substantia nigra pars reticulata), cerebellar molecular layer, innermost layers of the olfactory bulb, and portions of the hippocampal formation (CA3 and dentate gyrus molecular layer). Moderately dense binding is found throughout the remaining forebrain. Sparse binding characterizes the brain stem and spinal cord. Densitometry confirmed the quantitative heterogeneity of cannabinoid receptors (10 nM 3H-CP55,940 binding ranged in density from 6.3 pmol/mg protein in the substantia nigra pars reticulata to 0.15 pmol/mg protein in the anterior lobe of the pituitary). The results suggest that the presently characterized cannabinoid receptor mediates physiological and behavioral effects of natural and synthetic cannabinoids, because it is strongly coupled to guanine nucleotide regulatory proteins and is discretely localized to cortical, basal ganglia, and cerebellar structures involved with cognition and movement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CB1 receptors are localized to the central nervous system (CNS) and the periphery. CB1 receptors are found in sites associated with pain processing, including the periaqueductal gray (PAG),8 rostral ventromedial medulla (RVM),8 thalamus,9 dorsal root ganglia (DRG),10 amygdala,8 and cortex8.”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585
G PROTEINS: TRANSDUCERS OF RECEPTOR-GENERATED SIGNALS
Gilman, A. G. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.003151 · Cited by 6,405
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443
Self-citationIsolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
Self-citationThe organization of the projection from the cerebral cortex to the striatum in the rat
McGeorge, A. J., & Faull, R. L. M. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90128-0 · Cited by 1,360
Baserga, R. (1967) · JAMA · doi:10.1001/jama.1967.03130250093034 · Cited by 1,146
Hypoplasia of cerebellar vermal lobules VI and VII in autism
Courchesne, E., Yeung-Courchesne, R., Hesselink, J. R., & Jernigan, T. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805263182102 · Cited by 1,058
Rogers, A. W. (1967) · Medical Entomology and Zoology · Cited by 1,026
Kelley, A. E., Domesick, V. B., & Nauta, W. J. H. (1982) · Neuroscience · doi:10.1016/0306-4522(82)90067-7 · Cited by 888
Research works printed but not linked: 3
- Harris LS, Dewey WL, Razdan RK (1977) Cannabis. Its chemistry, pharmacology, and toxicology. In: Handbook of experimental phar- macology (Martin WR, ed), pp 37 l-%29. New York: Springer.
- Margulies JE, Hammer RP (1991) THC alters cerebral metabolism in limbic and cortical regions in a biphasic, dose-dependent manner. Ale Drug Res, in press.
- Pertwee RG (1985) Cannabis. In: Psychopharmacology 2, Pt 1: Pre- clinical psychopharmacology (Grahame-Smith DG, Cowan PJ, eds), pp 364-39 1. Amsterdam: Elsevier.
Cited by
Sorted by citations
Items 401–500 of 1,009
Adamczyk, P., Miszkiel, J., McCreary, A. C., Filip, M., Papp, M., & Przegaliński, E. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.030 · Cited by 114
Pistis, M., Perra, S., Pillolla, G., Melis, M., Gessa, G., & Muntoni, A. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.08.003 · Cited by 124
Balerio, G. N., Aso, E., Berrendero, F., Murtra, P., & Maldonado, R. J. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03714.x · Cited by 118
Sim‐Selley, L. J., Schechter, N. S., Rorrer, W. K., Dalton, G. D., Hernandez, J., Martin, B. R., & Selley, D. E. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.019612 · Cited by 115
Hill, M. N., & Gorzalka, B. B. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.06.069 · Cited by 119
Basavarajappa, B. S. (2007) · Current Neuropharmacology · doi:10.2174/157015907780866910 · Cited by 115
Mechanisms of CB1 receptor signaling: endocannabinoid modulation of synaptic strength
Mackie, K. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803273 · Cited by 122
Kempe, K. C., Hsu, F., Bohrer, A., & TURK, J. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17287 · Cited by 114
Cannabinoids and Multiple Sclerosis
Pertwee, R. G. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-0005-2 · Cited by 112
Griebel, G., Pichat, P., Beeské, S., Leroy, T., Redon, N., Jacquet, A., Françon, D., Bert, L., Even, L., Lopez‐Grancha, M., et al. (2015) · Scientific Reports · doi:10.1038/srep07642 · Cited by 113
Abush, H., & Akirav, I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031731 · Cited by 114
Nguyen, P., Schmid, C. L., Raehal, K. M., Selley, D. E., Bohn, L., & Sim‐Selley, L. J. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.11.027 · Cited by 113
Vinod, K. Y., Kassir, S. A., Hungund, B. L., Cooper, T. B., Mann, J. J., & Arango, V. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.11.013 · Cited by 114
Huang, H., Acuna, C., Li, Y., Cheng, H. M., Obrietan, K. H., & van den Pol, A. N. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0732-07.2007 · Cited by 115
Cannabidiol as a potential treatment for psychosis
Davies, C., & Bhattacharyya, S. (2019) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125319881916 · Cited by 121
Endocannabinoid system and opioid addiction: Behavioural aspects
Fattore, L., Deiana, S., Spano, S., Cossu, G., Fadda, P., Scherma, M., & Fratta, W. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.031 · Cited by 113
Romero, J., Berrendero, F., Pérez‐Rosado, A., Manzanares, J., Rojo, A., Fernández‐Ruíz, J., de Yébenes, J. G., & Ramos, J. A. (2000) · Life Sciences · doi:10.1016/s0024-3205(99)00618-9 · Cited by 112
Moreira, F. A., de Aguiar, D. C., Terzian, A. L. B., Guimarães, F. S., & Wotjak, C. T. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.046 · Cited by 113
Signaling via CNS cannabinoid receptors
Mackie, K. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.01.022 · Cited by 112
Role of endocannabinoids in brain development
Fernández‐Ruíz, J., Berrendero, F., Hernández, M., Romero, J., & Ramos, J. A. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00295-7 · Cited by 111
Endocannabinoids and related fatty acid derivatives in pain modulation
Walker, J. M., Krey, J. F., Chu, C. J., & Huang, S. M. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00152-4 · Cited by 113
Cardiovascular actions of cannabinoids and their generation during shock
Wagner, J. A., Varga, K. R., & Kunos, G. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050287 · Cited by 111
Pharmacology of Cannabinoid CB 1 and CB 2 Receptors
Pertwee, R. G. (1997) · Pharmacology & Therapeutics · Cited by 112
Tanda, G., Munzar, P., Goldberg, S. R., & Justinova, Z. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1693-6 · Cited by 111
Darmani, N. A., & Ray, A. P. (2009) · Chemical Reviews · doi:10.1021/cr900117p · Cited by 110
Cannabinoid–dopamine interactions in the physiology and physiopathology of the basal ganglia
García, C., Palomo‐Garo, C., Gómez‐Gálvez, Y., & Fernández‐Ruíz, J. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13215 · Cited by 111
Endocannabinoid and Opioid System Interactions in Exercise-Induced Hypoalgesia
Crombie, K. M., Brellenthin, A. G., Hillard, C. J., & Koltyn, K. F. (2017) · Pain Medicine · doi:10.1093/pm/pnx058 · Cited by 117
Learning Impairment Produced in Rats by the Cannabinoid Agonist HU 210 in a Water-Maze Task
Ferrari, F., Ottani, A., Vivoli, R., & Giuliani, D. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00106-9 · Cited by 111
Functional neuroanatomy of the endocannabinoid system
Pazos, M. R., NUNEZ, E., Benito, C., Tolón, R. M., & Romero, J. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.030 · Cited by 112
Rawls, S. M., Cabassa, J. C., Geller, E. B., & Adler, M. W. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.963 · Cited by 111
Cannabinoid Withdrawal Syndrome Is Reduced in Pre-Proenkephalin Knock-Out Mice
Valverde, O., Maldonado, R. J., Valjent, E., Zimmer, A. M., & Zimmer, A. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09284.2000 · Cited by 110
Neuronal localization of cannabinoid receptors and second messengers in mutant mouse cerebellum
Herkenham, M. A., Groen, B. G. S., Lynn, A. B., Costa, B., & Richfield, E. K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90096-e · Cited by 111
Self-citationTsou, K., Lowitz, K., Hohmann, A. G., Martin, W. J., Hathaway, C. B., Bereiter, D. A., & Walker, J. M. (1996) · Neuroscience · doi:10.1016/s0306-4522(96)83015-6 · Cited by 110
Selley, D. E., Stark, S., Sim, L. J., & Childers, S. R. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00347-5 · Cited by 111
Astroglia-specific contributions to the regulation of synapses, cognition and behaviour
Augusto‐Oliveira, M., Arrifano, G. D. P., Takeda, P. Y., Lopes-Araújo, A., Santos-Sacramento, L., Anthony, D. C., Verkhratsky, A., & Lopez, M. E. C. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.07.039 · Cited by 111
Silva, G. E. D., & Takahashi, R. N. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00275-5 · Cited by 110
Cannabinoids and gene expression during brain development
Fernández‐Ruíz, J., Gómez‐Ruíz, M., Hernández, M., de Miguel, R., & Ramos, J. A. (2004) · Neurotoxicity Research · doi:10.1007/bf03033314 · Cited by 110
Niyuhire, F., Varvel, S. A., Thorpe, A. J., Stokes, R. J., Wiley, J. L., & Lichtman, A. H. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0650-6 · Cited by 110
Neurochemical basis of cannabis addiction
Maldonado, R. J., Berrendero, F., Ozaita, A., & Robledo, P. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.02.035 · Cited by 113
Institute of Medicine (1999) · National Academies Press eBooks · doi:10.17226/6376 · Cited by 114
Cannabinoids modulate pain by multiple mechanisms of action
Richardson, J. D. (2000) · The Journal of Pain · doi:10.1016/s1526-5900(00)90082-8 · Cited by 109
Orío, L., Edwards, S., George, O., Parsons, L. H., & Koob, G. F. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0563-09.2009 · Cited by 111
Köfalvi, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3 · Cited by 110
Basavarajappa, B. S., Nagre, N. N., Xie, S., & Subbanna, S. (2014) · Hippocampus · doi:10.1002/hipo.22272 · Cited by 107
Expression of cannabinoid CB 1 receptor mRNA in basal ganglia of normal and parkinsonian human brain
Hurley, M. J., Mash, D. C., & Jenner, P. G. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-003-0033-7 · Cited by 109
Zhuang, S.-Y., Kittler, J. T., Grigorenko, E. V., Kirby, M. T., Sim, L. J., Hampson, R. E., Childers, S. R., & Deadwyler, S. A. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00232-0 · Cited by 109
Mateos, B., Borcel, E., Loriga, R., Luesu, W., Bini, V, Llorente, R., Castelli, M., & Viveros, M.-P. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110370503 · Cited by 108
Lever, I. J., & Rice, A. S. C. (2007) · Springer eBooks · doi:10.1007/978-3-540-33823-9_10 · Cited by 108
DEOLIVEIRAALVARES, L., De-Oliveira, L. M., de Almeida, C. C. S., Diehl, F., Genro, B. P., Lanziotti, V. M. N. B., & Quillfeldt, J. A. (2004) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2004.10.002 · Cited by 108
Hohmann, A. G., Tsou, K., & Walker, J. M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00802-7 · Cited by 108
Regulation of Peripheral Cannabinoid Receptor CB2Phosphorylation by the Inverse Agonist SR 144528
Bouaboula, M., Dussossoy, D., & Casellas, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.29.20397 · Cited by 107
Cannabinoids and Neuroprotection
Beltramo, M., Grundy, R. I., & Rabuffetti, M. (2001) · Molecular Neurobiology · doi:10.1385/mn:24:1-3:029 · Cited by 109
Meschler, J. P., & Howlett, A. C. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00012-0 · Cited by 107
The manifold actions of endocannabinoids on female and male reproductive events
Bari, M. (2010) · Frontiers in bioscience · doi:10.2741/3701 · Cited by 110
Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis
Nia, A. B., Medrano, B., Perkel, C., GALYNKER, I. I., & Hurd, Y. L. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116658990 · Cited by 107
Foll, B. L., Forget, B., Aubin, H., & Goldberg, S. R. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00113.x · Cited by 108
The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice
Shafaroodi, H., Samini, M., Moezi, L., Homayoun, H., Sadeghipour, H., Tavakoli, S., Hajrasouliha, A. R., & Dehpour, A. R. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.04.011 · Cited by 105
Gorzalka, B. B., Hill, M. N., & Chang, S. (2009) · Hormones and Behavior · doi:10.1016/j.yhbeh.2009.08.009 · Cited by 108
The role of endocannabinoids in pain modulation
Zogopoulos, P., Vasileiou, I., Patsouris, E., & Theocharis, S. E. (2013) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12008 · Cited by 112
Fried, P. A. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00203-i · Cited by 106
Sierra, S., Luquin, N., Rico, A. J., Gómez-Bautista, V., Roda, E., Dopeso‐Reyes, I. G., Vázquez, A., Martínez‐Pinilla, E., Labandeira-García, J. L., Franco, R., et al. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0823-8 · Cited by 105
Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus
Gamber, K. M., Macarthur, H., & Westfall, T. C. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.04.017 · Cited by 107
Nackley, A. G., Suplita, R. L., & Hohmann, A. G. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00870-9 · Cited by 103
Nestor, L. J., Roberts, G. M. P., Garavan, H., & Hester, R. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2007.12.059 · Cited by 111
The Multiplicity of Action of Cannabinoids: Implications for Treating Neurodegeneration
Gowran, A., Noonan, J., & Campbell, V. A. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00195.x · Cited by 109
Wenzel, J. M., Oleson, E. B., Gove, W. N., Cole, A. B., Gyawali, U., Dantrassy, H. M., Bluett, R. J., Dryanovski, D. I., Stuber, G. D., Deisseroth, K. A., et al. (2018) · Current Biology · doi:10.1016/j.cub.2018.03.037 · Cited by 102
SR141716A, a cannabinoid CB1 receptor antagonist, improves memory in a delayed radial maze task
Wolff, M. C., & Leander, J. D. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.025 · Cited by 103
Lastres‐Becker, I., Berrendero, F., Lucas, J. J., Martı́n-Aparicio, E., Yamamoto, A., Ramos, J. A., & Fernández‐Ruíz, J. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03403-5 · Cited by 103
Cannabinoids and Neuroprotection in Basal Ganglia Disorders
Sagredo, O., Garcı́a-Arencibia, M., de Lago, E., Finetti, S., Decio, A., & Fernández‐Ruíz, J. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-0004-3 · Cited by 103
Darmani, N. A. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00531-7 · Cited by 103
Chang, M. C., Berkery, D., Schuel, R., Laychock, S. G., Zimmerman, A. M., Zimmerman, S. B., & Schuel, H. (1993) · Molecular Reproduction and Development · doi:10.1002/mrd.1080360416 · Cited by 103
SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance
Nazzaro, C., Greco, B., Cerovic, M., Baxter, P. S., Rubino, T., Trusel, M., Parolaro, D., Tkatch, T., Benfenati, F., Pedarzani, P., et al. (2012) · Nature Neuroscience · doi:10.1038/nn.3022 · Cited by 103
The human eye expresses high levels of CB1 cannabinoid receptor mRNA and protein
Porcella, A., Maxia, C., Gessa, G. L., & Pani, L. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.01027.x · Cited by 102
Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids
Puighermanal, E., Busquets-García, A., Maldonado, R. J., & Ozaita, A. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0384 · Cited by 104
Hohmann, A. G., & Herkenham, M. A. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00534-5 · Cited by 102
Self-citationTao, Q., & Abood, M. E. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37469-5 · Cited by 101
Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat
Beaulieu, P., Bisogno, T., Punwar, S., Farquhar-Smith, W. P., Ambrosino, G., Marzo, V. D., & Rice, A. S. C. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00226-0 · Cited by 101
Lovell, M. E., Akhurst, J., Padgett, C. R., Garry, M. I., & Matthews, A. J. (2019) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000326 · Cited by 111
Mukhopadhyay, S., McIntosh, H. H., Houston, D. B., & Howlett, A. C. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26454-3 · Cited by 101
Romero, J., García‐García, L., Fernández‐Ruíz, J., Cebeira, M., & Ramos, J. A. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00023-p · Cited by 100
Verty, A. N. A., McFarlane, J. R., McGregor, I. S., & Mallet, P. E. (2004) · Endocrinology · doi:10.1210/en.2004-0059 · Cited by 100
de Lago, E., de Miguel, R., Lastres‐Becker, I., Ramos, J. A., & Fernández‐Ruíz, J. (2004) · Brain Research · doi:10.1016/j.brainres.2004.02.016 · Cited by 100
Alvares, L. D. O., Genro, B. P., Diehl, F., & Quillfeldt, J. A. (2008) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2008.01.009 · Cited by 99
Regulation of brain anandamide by acute administration of ethanol
Ferrer, B., Bermúdez‐Silva, F. J., Bilbao, A., Alvarez‐Jaimes, L., Sánchez-Vera, I., Giuffrida, A., Serrano, A., Baixerás, E., Khaturia, S., Navarro, M. A., et al. (2007) · Biochemical Journal · doi:10.1042/bj20061898 · Cited by 100
Akirav, I. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00034 · Cited by 102
Learning about stress: neural, endocrine and behavioral adaptations
McCarty, R. C. (2016) · Stress · doi:10.1080/10253890.2016.1192120 · Cited by 103
Type-1 Cannabinoid Receptor Signaling in Neuronal Development
Gaffuri, A.-L., Ladarré, D., & Lenkei, Z. (2012) · Pharmacology · doi:10.1159/000339075 · Cited by 107
Functional Relevance of Endocannabinoid-Dependent Synaptic Plasticity in the Central Nervous System
Augustin, S. M., & Lovinger, D. M. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00508 · Cited by 100
Inhibition of pain responses by activation of CB2 cannabinoid receptors
Malan, T. P., Ibrahim, M. M., Vanderah, T. W., Makriyannis, A., & Porreca, F. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00155-x · Cited by 99
Altered responsiveness of serotonin receptor subtypes following long-term cannabinoid treatment
Hill, M. N., Sun, J. C., Tse, M., & Gorzalka, B. B. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005651 · Cited by 98
Dynamic Regulation of the Endocannabinoid System: Implications for Analgesia
Sagar, D. R., Gaw, A. G., Okine, B. N., Woodhams, S. G., Wong, A., Kendall, D. A., & Chapman, V. (2009) · Molecular Pain · doi:10.1186/1744-8069-5-59 · Cited by 99
Waes, V. V., Beverley, J. A., Siman, H., Tseng, K. Y., & Steiner, H. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00021 · Cited by 94
Endocannabinoid system involvement in brain reward processes related to drug abuse
Solinas, M., Yaşar, S., & Goldberg, S. R. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.005 · Cited by 102
Rodgers, R. J., Evans, P., & Murphy, A. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00013 · Cited by 101
Irving, A. J., Coutts, A. A., Harvey, J., Rae, M. G., Mackie, K., Bewick, G. S., & Pertwee, R. G. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00120-2 · Cited by 96
Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice
Umathe, S. N., Manna, S. S. S., & Jain, N. S. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.04.031 · Cited by 98
Solinas, M., Panlilio, L. V., Tanda, G., Makriyannis, A., Matthews, S. A., & Goldberg, S. R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300754 · Cited by 103
Inhibitory effects of SR141716A on G-protein activation in rat brain
Sim‐Selley, L. J., Brunk, L. K., & Selley, D. E. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00784-1 · Cited by 95
Alvares, L. D. O., Genro, B. P., Breda, R. V., Pedroso, M. F., da Costa, J. C., & Quillfeldt, J. A. (2006) · Brain Research · doi:10.1016/j.brainres.2005.11.101 · Cited by 95
Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions
Mendizábal, V. E., & Adler‐Graschinsky, E. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707261 · Cited by 101
Metadata
- Authors
- Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Herkenham, M
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 1991-02-01
- Volume
- 11
- Issue
- 2
- Pages
- 563-583
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6575215
- OpenAlex
- W1836729582
- Cited by
- 2,159
- References
- 65
- Citations by year
- 2026: 23 · 2025: 23 · 2024: 43 · 2023: 56 · 2022: 64 · 2021: 65 · 2020: 84 · 2019: 61 · 2018: 74 · 2017: 70 · 2016: 70 · 2015: 95 · 2014: 77 · 2013: 74 · 2012: 86
- FWCI
- 14.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- cannabinoid receptors, receptor localization, receptor density, G protein coupling, enantioselectivity, basal ganglia, cerebellar molecular layer, olfactory bulb, hippocampus, substantia nigra pars reticulata, pituitary gland, rat brain
- MeSH terms
- Animals, Autoradiography, Brain, Buffers, Cannabinoids, Cyclohexanols, Male, Rats, Inbred Strains, Receptors, Drug, Serum Albumin, Bovine, Temperature, Time Factors, Tissue Distribution, Receptors, Cannabinoid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review